
Keywords: HVD; half value duration; AUC(0-â); area under plasma drug concentration; AUMC; area under the first moment curve; t1/2; elimination half life; MRT; mean residence time.; Glioma; Blood-brain barrier (BBB); Polymer-lipid hybrid nanoparticles (PLNs)